Other Events ·
InfuSystem Holdings, Inc. filed a Form 8-K to furnish an investor presentation dated August 4, 2026, under Regulation FD
INFUInfuSystem Holdings, Inc
InfuSystem Holdings, Inc. filed a Form 8-K to furnish an investor presentation dated August 4, 2026, under Regulation FD. The presentation highlights the company's transition from an investment phase to accelerated margin expansion following the completion of a $2.6 million IT and ERP upgrade in early 2026. For fiscal year 2025, InfuSystem reported net revenue of $143.4 million, a 6% increase year-over-year, with adjusted EBITDA reaching $31.5 million, up 25%. The company operates a home healthcare services platform that delivers complex therapies, such as oncology infusion and wound care, outside hospital settings through embedded reimbursement, logistics, and clinical support.